Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

TeleClinic vs Willow

TeleClinic
Graded #313

Higher grade

vs+2.5999999999999943
Willow
Graded #377

Lower grade

The verdict

TeleClinic takes it — 60.8/100 to 58.2/100.

TeleClinic grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleClinic (Teleclinic Holdings LLC) is a US telehealth platform offering physician-prescribed compounded GLP-1 weight-loss medication — semaglutide and tirzepatide — shipped from a licensed 503A…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTeleClinic +8
44
36
Dose & formulationWillow +11
64
75
Clinical oversightTeleClinic +9
80
71
Labs & monitoringEven
52
52
FulfillmentTeleClinic +32
97
65
Contract termsWillow +35
20
55
TeleClinic · left barWillow · right bar

The numbers

MetricTeleClinicWillow
WeighScore60.8/10058.2/100
GradeCC
Scorecard rank#313#377
Semaglutide$199/mo (compounded)$299/mo (starting dose, compounded)
Tirzepatide$299/mo (compounded)$399/mo (starting dose, compounded)
Coverage47 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
TeleClinic

Graded #313 · C

Strengths

  • Names its pharmacy partner — Rush Pharmacy, a licensed 503A compounder — which many compounded-GLP-1 telehealths won't disclose
  • LegitScript certified with flat, published monthly pricing, free shipping, and no insurance required
  • Broad access: 47 states with US-licensed physicians and transparent cash-pay pricing

Where it loses points

  • Compounded semaglutide and tirzepatide only — no brand-name GLP-1 (Wegovy or Zepbound) option
  • Headline $139/$219 rates are first-quarter intro prices billed quarterly; ongoing month-to-month is $199/$299
  • Not available in California, South Carolina, or New Jersey
Willow

Graded #377 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard